"If we can identify biologic pathways that could be interfered with in patients who show risk factors for future bad respiratory events, we could change the game and intercept lung disease before it's clinically apparent," said Ravi Kalhan, MD.
"We know that people who are experiencing accelerated decline in their lung function are at risk of developing severe COPD or having other health problems in the long run. If we could figure out who those people are, it would open the doors of possibilities for how we can think about blocking this unfavorable trajectory in their lung function," added Kalhan.
Collection
[
|
...
]